Insider Cluster (2 insiders) ·Filed Aug 20, 2026

HALO

HALOZYME THERAPEUTICS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $256K total
Actionable Insight • Neutral

This insider cluster is routine and non-informative. CEO Torley's pattern of exercising deep-in-the-money options ($18.41 strike vs ~$105 market price) and immediately selling is standard compensation-related activity. Monitor for any upcoming earnings or pipeline catalysts, but this filing provides no actionable trading signal.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
HALO ▲ +5.96% at T+20d
NEUTRAL call ✓ call won +5.96% · α vs SPY +5.96% · entry $106.12 → $112.45
Next anchor: T+60d in 6w
Latest observation: T+27 -14.51% FF3 residual α
Entry anchored
Aug 19, 07:12 PM ET
via 1-min bar
T+1d
+1.93%
call +1.93% · α +1.52%
$108.17
settled 6w ago
T+5d
+0.75%
call +0.75% · α -0.36%
$106.92
settled 5w ago
T+20d
+5.96%
call +5.96% · α +5.96%
$112.45
settled 15d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

CEO Helen Torley executed a large-scale option exercise and open-market sale program over Aug 17-19, 2026, selling a total of ~50,000 shares for ~$5.3M. Director Bernadette Connaughton also sold 1,600 shares for $167K on Aug 10. The CEO's sales are part of a routine, pre-planned exercise-and-sell pattern tied to option exercises at $18.41, generating no net economic signal — the shares were acquired and immediately sold at market prices. The cluster represents 0.04% of HALO's $11.9B market cap, well below the 0.1% materiality threshold, making this a routine, non-informative event.

Key Financial Metrics

Direction
selling
Total Value
$5.5M
Insiders
2

Key Facts

  • CEO Torley exercised 80,000 options at $18.41 and sold ~50,000 shares on the open market for ~$5.3M over Aug 17-19
  • Director Connaughton sold 1,600 shares for $167K on Aug 10
  • Total cluster value of ~$5.5M represents 0.05% of HALO's $11.9B market cap
  • All CEO sales were same-day exercises followed by open-market sales — a classic tax-withholding/vesting pattern, not a directional bet
  • HALO has 75% analyst bullish consensus and strong institutional ownership (BlackRock $1.0B)

Financial Impact

$5.5M in insider sales, 0.05% of market cap — immaterial

Risk Factors

  • CEO selling ~$5.3M could be misinterpreted as bearish by retail traders
  • No material risk — this is a routine compensation event

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (16 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-HALO-1787185221091
6 reports for HALO
Performance horizon
Filters
Rows
Reports for HALO — sortable, filterable
TypeNow
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$106.12 $112.45▲ +5.96%▲ +5.96%$109.31 (+3.01%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$78.62 $85.76▲ +9.08%▲ +6.84%$109.31 (+39.04%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$79.45 $83.30▲ +4.85%▲ +5.26%$109.31 (+37.58%)
Jun 4, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.60 $79.45▲ +10.96%▲ +12.34%$109.31 (+52.67%)
Apr 30, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$63.66 $68.18▲ +7.10%▲ +2.13%$109.31 (+71.71%)
Mar 23, 2026
27w ago
DEFA14A
NEUTRAL ★ 2/10
$62.04 $68.40▲ +10.25%▲ +1.35%$109.31 (+76.19%)
Showing 6 of 6

US Market Status

Market Open — Closes in 3h 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 20, 2026